Cargando…
Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s Perspective
Oncology is one of the most important fields of personalized medicine as a majority of efforts in this field have recently centered on targeted cancer drug development. New tools are continuously being developed that promise to make cancer treatment more efficacious while causing fewer side effects....
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251362/ https://www.ncbi.nlm.nih.gov/pubmed/25562700 http://dx.doi.org/10.3390/jpm2010015 |
_version_ | 1782347043051667456 |
---|---|
author | Fleck, Roman Bach, Daniel |
author_facet | Fleck, Roman Bach, Daniel |
author_sort | Fleck, Roman |
collection | PubMed |
description | Oncology is one of the most important fields of personalized medicine as a majority of efforts in this field have recently centered on targeted cancer drug development. New tools are continuously being developed that promise to make cancer treatment more efficacious while causing fewer side effects. Like most industries, the biopharmaceutical industry is also following certain global trends and these are analyzed in this article. As academia and industry are mutually dependent on each other, researchers in the field should be aware of those trends and the immediate consequences for their research. It is important for the future of this field that there is a healthy relationship among all interested parties as the challenges of personalized medicine are becoming ever more complex. |
format | Online Article Text |
id | pubmed-4251362 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-42513622014-12-15 Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s Perspective Fleck, Roman Bach, Daniel J Pers Med Opinion Oncology is one of the most important fields of personalized medicine as a majority of efforts in this field have recently centered on targeted cancer drug development. New tools are continuously being developed that promise to make cancer treatment more efficacious while causing fewer side effects. Like most industries, the biopharmaceutical industry is also following certain global trends and these are analyzed in this article. As academia and industry are mutually dependent on each other, researchers in the field should be aware of those trends and the immediate consequences for their research. It is important for the future of this field that there is a healthy relationship among all interested parties as the challenges of personalized medicine are becoming ever more complex. MDPI 2012-03-07 /pmc/articles/PMC4251362/ /pubmed/25562700 http://dx.doi.org/10.3390/jpm2010015 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Opinion Fleck, Roman Bach, Daniel Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s Perspective |
title | Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s Perspective |
title_full | Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s Perspective |
title_fullStr | Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s Perspective |
title_full_unstemmed | Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s Perspective |
title_short | Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s Perspective |
title_sort | trends in personalized therapies in oncology: the (venture) capitalist’s perspective |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251362/ https://www.ncbi.nlm.nih.gov/pubmed/25562700 http://dx.doi.org/10.3390/jpm2010015 |
work_keys_str_mv | AT fleckroman trendsinpersonalizedtherapiesinoncologytheventurecapitalistsperspective AT bachdaniel trendsinpersonalizedtherapiesinoncologytheventurecapitalistsperspective |